Company Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.
The company provides its systems for use by people with diabetes, as well as for use by healthcare providers.
Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system.
The company's products candidature comprises Dexcom G7, a next generation G7 CGM system.
DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products.
The company markets its products directly to endocrinologists, physicians, and diabetes educators.
DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
| Country | United States |
| IPO Date | Apr 14, 2005 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 9,500 |
| CEO | Kevin Ronald Sayer |
Contact Details
Address: 6340 Sequence Drive San Diego, California United States | |
| Website | https://www.dexcom.com |
Stock Details
| Ticker Symbol | DXCM |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001093557 |
| CUSIP Number | 252131107 |
| ISIN Number | US2521311074 |
| Employer ID | 33-0857544 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Kevin Ronald Sayer | Executive Chairman, Chief Executive Officer & President |
| Girish Naganathan | Executive Vice President & Chief Technology Officer |
| Jacob Steven Leach | Executive Vice President & Chief Operating Officer |
| Jereme M. Sylvain CPA | Executive Vice President, Chief Financial Officer & Chief Accounting Officer |
| Michael Jon Brown | Executive Vice President & Chief Legal Officer |
| Donald M. Abbey | Executive Vice President of Global Business Services, Quality & Regulatory Affairs |
| Leverne Marsh | Executive Vice President of Marketing |
| Matthew Dolan | Executive Vice President of Strategy, Corporate Development & Dexcom Labs |
| Sadie M. Stern | Executive Vice President & Chief Human Resources Officer |
| Sean Christensen | Director of Corporate Affairs & Head of Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 23, 2024 | 8-K | Current Report |
| Dec 17, 2024 | 4 | Filing |
| Dec 17, 2024 | 4 | Filing |
| Dec 17, 2024 | 4 | Filing |
| Dec 17, 2024 | 4 | Filing |
| Dec 06, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 22, 2024 | 4 | Filing |
| Nov 18, 2024 | 4 | Filing |
| Oct 24, 2024 | 10-Q | Quarterly Report |
| Oct 24, 2024 | 8-K | Current Report |